Compare Illumina, Inc. (ILMN) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs McKesson Corporation — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while McKesson Corporation trades at $898 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 3.6× Illumina, Inc.'s market cap, and McKesson Corporation pays a 0.42% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | MCK | |
|---|---|---|
Market Cap | $29.12B | $105.14B |
Sector | Health | Health |
52-Week High | $205.10 | $995.69 |
52-Week Low | $91.00 | $659.01 |
Enterprise Value | $30.48B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
